Search

everythinglearnresearchcommunity

for

Search:↓

Platelet-rich plasma (PRP) injections can effectively increase hair density and thickness in people with androgenic alopecia, without major side effects.

Androgenetic alopecia is significantly linked to metabolic syndrome.

Different types of RNAs are found in varying amounts in patients with Polycystic Ovary Syndrome, suggesting they could be important in the disease's development and potentially used as disease markers.

Severe and early hair loss may indicate a higher risk of heart disease.

Adult acne is often related to hormonal disorders, especially in women, and may need long-term treatment involving specialists.

Dihydrotestosterone and 5α-Reductase play a role in hair loss and prostate health, and finasteride can increase hair growth in men without affecting sperm production, but it doesn't work for postmenopausal women with hair loss.

People with early-onset androgenetic alopecia may have a higher risk of heart disease due to abnormal blood lipid levels.

The review suggests that while many AKR1C3 inhibitors show promise for treating certain cancers, more research is needed to confirm their effectiveness in humans.

Hydroxyl radicals cause hair follicle cell death during chemotherapy by reducing Bcl-2 protein levels.

The protein STAT3 slows down cell growth by blocking the FST gene, which affects hair development in sheep.

Eating a Mediterranean diet and taking certain supplements may improve symptoms of PCOS.

Clinical signs of hyperandrogenism are related to female pattern hair loss severity, but biochemical markers are not.

Identified genes linked to male-pattern baldness may help develop new treatments.

Platelet Rich Plasma (PRP) injections can improve hair count, thickness, and strength in people with androgenic alopecia.

People with androgenetic alopecia, both men and women, are more likely to develop heart diseases in the future.

Minoxidil and Finasteride are effective for male baldness; more research is needed for hair aging treatments.

Hair loss in middle-aged women is often linked to insulin resistance and a family history of hair loss, particularly from their fathers.

People with androgenetic alopecia have a higher risk of metabolic syndrome.

Most women with PCOS have insulin resistance, especially those with phenotype B.

Platelet-Rich Plasma therapy helps increase hair density and regrowth for some types of hair loss.

Men with baldness, ear creases, and hairy ears have a higher risk of heart disease.

Non-daily contraceptives cause fewer side effects and are more satisfying to women, and certain oral contraceptives can treat acne and seborrhoea, with a combination of chlormadinone acetate and ethinyl estradiol being highly effective and safe.

People with androgenetic alopecia are more likely to have metabolic syndrome.

Purple sweet potato leaf extracts can help treat hair loss and fungal infections.

The nature of the side chain in RU 58841 derivatives greatly affects its AR affinity, with the N-(iodopropenyl) derivative 13 showing the highest AR binding affinity, suggesting its potential for developing high-affinity radioiodinated AR radioligands.

Scientists created iodinated arylhydantoins and arylthiohydantoins that could potentially be used for imaging prostate cancer. Some versions with specific side-chains showed high potential for this use.

Finasteride helps treat hair loss by blocking enzyme activity.

The more lipophilic the progesterone derivative, the better it binds to androgen receptors and has antiandrogenic effects.

Proscar (finasteride) blocks 5α-reductase in sea urchin ovaries and testes, suggesting potential treatment for androgen-related conditions.